3.05
0.01 (0.33%)
0.01 (0.33%)
Upgrade to Real-Time
Afterhours (Closed)
Low
2.15
High
6.25
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.01 | 0.33% | 3.05 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.05 | 2.97 | 3.10 | 3.05 | 3.04 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.82 | 3.10 | 0.28 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 294 | 65,987 | $ 3.04 | $ 200,569 | - | 2.15 - 6.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:06:19 | 2 | $ 3.08 | USD |
Period:
Draw Mode:
Galmed Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 64.39M | 21.11M | 17.58M | $ - | $ - | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Galmed Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.02 | 3.10 | 2.82 | 2.98 | 106,368 | 0.03 | 0.99% |
| 1 Month | 3.10 | 3.39 | 2.82 | 3.12 | 99,440 | -0.05 | -1.61% |
| 3 Months | 3.21 | 3.42 | 2.37 | 2.92 | 246,457 | -0.16 | -4.98% |
| 6 Months | 3.77 | 4.08 | 2.15 | 3.08 | 265,755 | -0.72 | -19.1% |
| 1 Year | 3.86 | 6.25 | 2.15 | 3.61 | 261,703 | -0.81 | -20.98% |
| 3 Years | 12.83 | 14.6495 | 2.15 | 4.95 | 152,480 | -9.78 | -76.23% |
| 5 Years | 5.29 | 27.06 | 2.15 | 8.05 | 152,392 | -2.24 | -42.34% |
Galmed Pharmaceuticals Description
| Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. |
